ddEC-wnP
Showing 1 - 6 of 6
Breast Cancer Trial in Hangzhou (Docetaxel, Carboplatin, Trastuzumab)
Recruiting
- Breast Cancer
- Docetaxel
- +6 more
-
Hangzhou, Zhejiang, China2nd Affiliated Hospital, School of Medicine, Zhejiang University
Jun 28, 2022
Breast Cancer Trial in Hangzhou (Docetaxel, Carboplatin, Trastuzumab)
Recruiting
- Breast Cancer
- Docetaxel
- +6 more
-
Hangzhou, Zhejiang, China2nd Affiliated Hospital, School of Medicine, Zhejiang University
Jun 28, 2022
HER-2 Positive Breast Cancer Trial in Tianjin (TCbHP VS ddEC-THP)
Recruiting
- HER-2 Positive Breast Cancer
- TCbHP VS ddEC-THP
-
Tianjin, Tianjin, ChinaBreast Oncology, Tianjin Medical University Cancer Institute and
May 15, 2023
Breast Cancer, Neutropenia Trial in Beijing (PEG-rhG-CSF)
Completed
- Breast Cancer
- Neutropenia
-
Beijing, Beijing, ChinaBeijing Cancer Hospital
Oct 26, 2020
HER2-negative Breast Cancer, Neoadjuvant Chemo Trial in Hangzhou (Epirubicin, Cyclophosphamid, Docetaxel)
Recruiting
- HER2-negative Breast Cancer
- Neoadjuvant Chemotherapy
- Epirubicin
- +3 more
-
Hangzhou, Zhejiang, China2nd Affiliated Hospital, School of Medicine, Zhejiang University
Aug 9, 2021